Αρχειοθήκη ιστολογίου

Πέμπτη 3 Αυγούστου 2017

Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation

Voriconazole has previously been associated with increased risk for cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients. Less is known about the risk in patients after hematopoietic cell transplantation (HCT).

http://ift.tt/2uYSUCA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου